A5101917498- Esophageal and GI Pathology
- Dysphagia Assessment and Management
- Gastroesophageal reflux and treatments
- Systemic Lupus Erythematosus Research
- Gastrointestinal disorders and treatments
- Rheumatoid Arthritis Research and Therapies
- Cardiac Imaging and Diagnostics
- Hepatitis C virus research
- Heart Failure Treatment and Management
- Renal and Vascular Pathologies
- Cardiovascular Function and Risk Factors
- Peripheral Artery Disease Management
- Torture, Ethics, and Law
- Esophageal Cancer Research and Treatment
- Vascular Procedures and Complications
Thomas Jefferson University
2020-2021
Bristol-Myers Squibb (United States)
2017
AstraZeneca (United States)
2007
Yeshiva University
2006
Using the North American Rheumatoid Arthritis Consortium (NARAC) candidate gene and genome-wide single-nucleotide polymorphism (SNP) data sets, we applied regression methods tree-based random forests to identify genetic associations with rheumatoid arthritis (RA) predict RA disease status. Several genes were consistently identified as weakly associated without a significant interaction or combinatorial effect other genes. forests, tested SNPs not sufficient patients normal subjects high...
INTRODUCTION: Peroral endoscopic myotomy (POEM) is a safe and effective treatment for range of esophageal disorders. Most cases premature POEM termination are attributed to submucosal fibrosis preventing tunneling, thought be from prior or surgical treatments. While early research showed longer procedure times patients with treatments, more recent data no difference. The purpose this study was determine if increased times. METHODS: This retrospective conducted at single tertiary care center....